πŸ‡ΊπŸ‡Έ FDA
Patent

US 11033556

Bicyclic sulfonamides

granted A61KA61K31/554A61P

Quick answer

US patent 11033556 (Bicyclic sulfonamides) held by Aligos Therapeutics, Inc. expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aligos Therapeutics, Inc.
Grant date
Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/554, A61P, A61P31/14, A61P31/20